Sunflower Pharmaceutical Group Co., Ltd. (002737.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 16Sep 21

Key dataSep 21, 2026

OpenCNY 11.28

From 52W high−19.12%

Volume5.91M

Market capCNY 7.51B

P/E (TTM)−29.1x

P/S (TTM)2.7x

Div yield1.74%

Key dataSep 21, 2026

Open

CNY 11.28

From 52W high

−19.12%

Volume

5.91M

Market cap

CNY 7.51B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−70.3x

P/E (TTM)

−29.1x

RSI (14)

36.1

MomentumView details →

1D Return

−1.38%

YTD Return

−22.07%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−29.1x

EV/EBITDA

−70.3x

EV/Sales

2.2x

P/S (TTM)

2.7x

P/B (TTM)

2.0x

ProfitabilityView details →

Gross Margin

44.52%

Net Margin

−8.19%

EBITDA Margin

−3.14%

ROE (TTM)

−5.18%

ROA (TTM)

−3.82%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

−0.95%

EPS YoY

—

FCF YoY

+187.74%

Revenue CAGR 3Y

−23.09%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−1.38%

YTD Return

−22.07%

1Y Return

−26.31%

RSI (14)

36.1

vs 50D SMA

−10.13%

vs 200D SMA

−13.46%

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

3.33x

Quick Ratio

2.72x

Div Yield

1.74%

Div Rate

CNY 0.20

Div Growth 1Y

−60.00%

EarningsView details →

EPS (Actual)

−CNY 0.05

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.50B

Net Income (TTM)

−204.65M

Op. CF (TTM)

551.36M

Latest newsMore news →

Sunflower Pharmaceutical used 400 million yuan of idle self-owned funds to purchase fixed-income non-principal-protected floating-return wealth management products, involving products from China Merchants Bank, Industrial Bank, Shanghai Pudong Development Bank, and China CITIC Bank.3d ago

Kuihua Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 79.4695 million yuan, down 2.26% year-on-year, with revenue of 1.498 billion yuan, up 14.34%.24d ago

Similar companies

精研科技300709.SZ 万孚生物300482.SZ 亿道信息001314.SZ 山东赫达002810.SZ 五洲医疗301234.SZ 佛山照明000541.SZ Find similar companies →

Latest newsMore news →

Sunflower Pharmaceutical used 400 million yuan of idle self-owned funds to purchase fixed-income non-principal-protected floating-return wealth management products, involving products from China Merchants Bank, Industrial Bank, Shanghai Pudong Development Bank, and China CITIC Bank.3d ago Kuihua Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 79.4695 million yuan, down 2.26% year-on-year, with revenue of 1.498 billion yuan, up 14.34%.24d ago